Kerr Douglas Insider Trading Activity
Kerr Douglas has been net-selling over the last 12 months with 0 purchases and 5 sales across 1 company.
DYN is the most-traded position with 5 trades. The largest single transaction was a sale of DYN for $47K on Sep 4, 2025.
Performance Scorecard
Forward stock performance after each transaction by Kerr Douglas. Buy returns measure price movement after open-market purchases; sell-avoided measures the loss avoided after open-market sales. Success rate counts trades where the insider's direction was right.
| PERIOD | AVG BUY RETURN | AVG SELL AVOIDED | SUCCESS RATE | TRADES |
|---|---|---|---|---|
| 30 days | — | +6.5% | 83% | 6 |
| 90 days | — | -20.1% | 20% | 5 |
| 120 days | — | -23.0% | 40% | 5 |
Performance based on stock price movement after each transaction date. Past results do not predict future returns. Not financial advice.
Price & Trades
Pro: Trade MarkersDYN · Dyne Therapeutics, Inc.
🔒 Subscribe to see trade entries
Pro members see exactly when Kerr Douglas bought and sold DYN.
Upgrade to ProRecent Trades
| DATE | TICKER | TYPE | SHARES | PRICE | VALUE | Δ OWNED | ROLE | FILING |
|---|---|---|---|---|---|---|---|---|
May 13, 2026 | DYN | Sell | 1,564 | $18.36 | $29K | −0.9% | Chief Medical Officer | |
Mar 5, 2026 | DYN | Sell | 904 | $14.90 | $13K | −0.5% | Chief Medical Officer | |
Dec 5, 2025 | DYN | Sell | 880 | $20.72 | $18K | −1.0% | Chief Medical Officer | |
Sep 5, 2025 | DYN | Sell | 873 | $13.41 | $12K | −1.0% | Chief Medical Officer | |
Sep 4, 2025 | DYN | Sell | 3,552 | $13.27 | $47K | −3.8% | Chief Medical Officer | |
Jun 5, 2025 | DYN | Sell | 1,342 | $13.35 | $18K | −1.4% | Chief Medical Officer |
Top Companies Traded
| TICKER | COMPANY | TRADES | TOTAL VOLUME |
|---|---|---|---|
| DYN | Dyne Therapeutics, Inc. | 6 | $137K |
Other insiders at Dyne Therapeutics, Inc.
5 other tracked filers at DYN.